CVRdatabase
Menu

Serodus ApS

Private limited companyCVR 31888263København NActive

Serodus ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2008. Equity was negative at the end of 2025 (−DKK 3.2m). The company made a loss in both 2024 and 2025, most recently DKK 4.7m. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 4m−593.7% vs. 2024
Net profit−DKK 4.7m−563.3% vs. 2024
Equity−DKK 3.2m−306.5% vs. 2024
Employees3latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 594% (2024 → 2025), to −DKK 4m.
  • The loss grew: from DKK 713k to DKK 4.7m (2024 → 2025).
  • Equity turned negative: −DKK 3.2m (2024 → 2025).

Employees

  • 2 more employees than a year earlier: 3 (08/2026) against 1 (08/2025).

Management and owners, last 24 months

  • New in management: Lars Smedegaard Andersen (ceo, 07/09/2026).
  • Stepped down: Eva Steiness (ceo, 07/09/2026).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2mDKK 3m202020212022202320242025
EquityNet profit
Financial figures for Serodus ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−1,259−1,808−351705818−4,039−593.7%
Operating profit (EBIT)–––−547−710−5,558−683.3%
Profit before tax–−1,922−368–−713−5,708−701.1%
Net profit−1,290−1,438−368−549−713−4,726−563.3%
Total assets6133,2082,8322,4241,6852,140+27%
Equity−1,139−2,5772,8042,2551,542−3,184−306.5%
Liabilities1,7525,785281691425,324+3,641.1%
Cash and cash equivalents3062,5442,7641,45260271−88.3%
Average number of employees–––1110%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 3.2m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Serodus ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202509/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202402/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202327/02/2024The companyPDFXBRL
202201/01/2022 – 31/12/202230/01/2023The companyPDFXBRL
202101/01/2021 – 31/12/202111/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202002/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
011223309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 4mNo. 369 of 421
Better than 12% of the companies in the industry
Equity−DKK 3.2mNo. 370 of 431
Better than 14% of the companies in the industry
Number of employees3No. 351 of 431
Better than 19% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,470of 69,742
Better than 0%
No. 68,779of 69,964
Better than 2%
Same industry and fewer than 20 employees329 companies in the comparison
No. 289of 323
Better than 11%
No. 280of 329
Better than 15%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 24,695of 24,791
Better than 0%
No. 24,562of 24,909
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 66,152of 66,379
Better than 0%
No. 65,316of 66,505
Better than 2%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Serodus ApS−DKK 4m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Serodus ApS−DKK 4.7m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Serodus ApS−DKK 3.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Serodus ApS3
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Serodus AS100%
Serodus ApS

Management

5 active registrations

Executive management

Executive management at Serodus ApS
NameRoleAppointed
Lars Smedegaard AndersenCEO07/09/2026

Board of directors

Board of directors at Serodus ApS
NameRoleAppointed
Søren Elmann IngerslevChair of the board08/02/2023
Viggo Gunnersen HarboeBoard member08/02/2023
Arnstein Gunnestad EndresenBoard member08/02/2023
Lars Beck-ThomsenBoard member30/06/2024
Founders
Es af 1. Juli 2000 ApS, Viggo Harboe 2006 Holding ApS, Neoloch ApS
Former management (7)
Former management at Serodus ApS
NameRoleAppointedResigned
Eva SteinessChair of the board18/12/200821/10/2013
Søren Elmann IngerslevBoard member18/12/200821/10/2013
Elisabeth Marianne BockBoard member06/04/201121/10/2013
Volodymyr BerezinBoard member06/04/201121/10/2013
Torben Frank SkarsfeldtCEO01/03/201321/10/2013
Eva SteinessDirector21/10/201307/02/2023
Eva SteinessCEO08/02/202307/09/2026

Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af bestyrelsesformanden og den administrerende direktør i forening.

Address and production units

1 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (8)

  • BII Holdings A/SOther financial service activities n.e.c.
  • Skape Bio ApSResearch and experimental development on natural sciences and engineering
  • Agrobiomics ApSResearch and experimental development on natural sciences and engineering
  • Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
  • BioColor ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
Serodus ApSOle Maaløes Vej 3, 2200 København N31014953899

Purpose

Selskabets formål er at drive virksomhed gennem forskning og udvikling af lægemidler til behandling af sukkersyge og beslægtede sygdomme. Desuden yder selskabet konsulentbistand indenfor udvikling af lægemidler og administration af kliniske studier, samt hermed forbundet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

36 registered events
20263 changesmanagement 2 · accounts 1
  • Lars Smedegaard Andersen appointed ceo
  • Eva Steiness stepped down as ceo
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesmanagement 1 · accounts 1
  • Lars Beck-Thomsen appointed board member
  • Annual report for 2023 published
20237 changesname 1 · management 5 · accounts 1
  • Name changed from PHLOGO ApS to Serodus ApS
  • Eva Steiness appointed ceo
  • Søren Elmann Ingerslev appointed chair of the board
  • Viggo Gunnersen Harboe appointed board member
  • Arnstein Gunnestad Endresen appointed board member
  • Eva Steiness stepped down as director
  • Annual report for 2022 published
20222 changesaccounts 1 · capital 1
  • Annual report for 2021 published
  • Share capital changed from 314,920 DKK to 500,000 DKK
20212 changesaccounts 1 · address 1
  • Annual report for 2020 published
  • Moved to Ole Maaløes Vej 3, 2200 København N
20181 changecapital 1
  • Share capital changed from 313,920 DKK to 314,920 DKK
20139 changesmanagement 7 · ownership 1 · capital 1
  • Eva Steiness appointed director
  • Torben Frank Skarsfeldt stepped down as ceo
  • Elisabeth Marianne Bock stepped down as board member
  • Volodymyr Berezin stepped down as board member
  • Eva Steiness stepped down as chair of the board
  • Søren Elmann Ingerslev stepped down as board member
  • Serodus AS registered as owner (100%)
  • Share capital changed from 156,926 DKK to 313,920 DKK
  • Torben Frank Skarsfeldt appointed ceo
20112 changesmanagement 2
  • Elisabeth Marianne Bock appointed board member
  • Volodymyr Berezin appointed board member
20101 changecapital 1
  • Share capital changed from 150,000 DKK to 156,926 DKK
20092 changescapital 1 · industry 1
  • Share capital changed from 127,500 DKK to 150,000 DKK
  • Industry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20083 changesfounded 1 · management 2
  • Registered as PHLOGO ApS
  • Eva Steiness appointed chair of the board
  • Søren Elmann Ingerslev appointed board member

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction